Icon (ICLR) Non-Current Debt (2009 - 2026)
Icon's (ICLR) quarterly Non-Current Debt came in at $2.1 billion in Q2 2026, down 37.63% year-over-year from $3.4 billion in Q2 2025, and down 26.37% quarter-over-quarter from $2.9 billion in Q1 2026.
Analysis
Icon (ICLR) Non-Current Debt (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Non-Current Debt for 13 consecutive years, with $2.1 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Debt fell 37.63% year-over-year to $2.1 billion in Q2 2026; TTM through Jun 2026 was $2.1 billion, a 37.63% decrease from a year earlier, with the FY2025 full-year figure at $2.9 billion, down 15.42% from the prior year.
- Non-Current Debt was $2.1 billion for Q2 2026 at Icon, down from $2.9 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $5.1 billion in Q1 2022 and troughed at $2.1 billion in Q2 2026.
- A 5-year average of $3.7 billion and a median of $3.4 billion in 2024 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt soared 1559.28% in 2022 and slumped 37.63% in 2026, its largest moves.
- Over 5 years, Non-Current Debt stood at $4.6 billion in 2022, then fell by 20.3% to $3.7 billion in 2023, then declined by 7.34% to $3.4 billion in 2024, then decreased by 15.42% to $2.9 billion in 2025, then fell by 26.52% to $2.1 billion in 2026.
- The last three Non-Current Debt figures came in at $2.1 billion (Q2 2026), $2.9 billion (Q1 2026), and $2.9 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 13.71 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.11 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 2.62 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 1.04 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 481.59 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11 Bn |
| Mar 31, 2026 | 2.87 Bn |
| Dec 31, 2025 | 2.87 Bn |
| Sep 30, 2025 | 2.88 Bn |
| Jun 30, 2025 | 3.38 Bn |
| Mar 31, 2025 | 3.39 Bn |
| Dec 31, 2024 | 3.40 Bn |
| Sep 30, 2024 | 3.40 Bn |
| Jun 30, 2024 | 3.41 Bn |
| Mar 31, 2024 | 3.42 Bn |
| Dec 31, 2023 | 3.67 Bn |
| Sep 30, 2023 | 3.91 Bn |
| Jun 30, 2023 | 4.21 Bn |
| Mar 31, 2023 | 4.35 Bn |
| Dec 31, 2022 | 4.60 Bn |
| Sep 30, 2022 | 4.79 Bn |
| Jun 30, 2022 | 4.99 Bn |
| Mar 31, 2022 | 5.09 Bn |
| Dec 31, 2021 | 5.38 Bn |
| Sep 30, 2021 | 5.87 Bn |